Grifols To Divest 3 US Plasma Centers As Part Of $286M Deal
The Federal Trade Commission said Wednesday that Spanish health care giant Grifols SA will sell blood plasma collection centers in three U.S. cities in order to win the regulator's approval of...To view the full article, register now.
Already a subscriber? Click here to view full article